1-3 of 3
Joana Parreira
Close
Sort by
Journal Articles

An External Control for Mosunetuzumab Using Real-World Data in Follicular Lymphoma in the Third or Subsequent Lines of Systemic Therapy

Sarah F. McGough, Natasha Shamas, Jue Wang, Mahmoud Jaber, Binay Swarup, Marie-Helene Blanchet Zumofen, Bertrand Lautié, Joana Parreira, Michael C. Wei, Ashwini Shewade
Journal: Blood
Blood (2022) 140 (Supplement 1): 3658–3660.
https://doi.org/10.1182/blood-2022-159640
Published: 2022
Journal Articles

Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma

Peter Trask, Jaisson Bortolini, Shinya Rai, Antonio Salar, Miguel Canales, Dirk Klingbiel, Joana Parreira, Maud Deraet, Ekaterina Vorozheikina, Kai Hübel, Thomas Buchholz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1345.
https://doi.org/10.1182/blood-2021-147911
Published: 2021
Journal Articles

Consolidation Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Pieter Sonneveld, MDPhD, Meral Beksac, Professor, Bronno van der Holt, PhD, Meletios A. Dimopoulos, Angelo Michele Carella, Heinz Ludwig, Christoph Driessen, MD PhD, Ruth Wester, Roman Hajek, Sandra Croockewit, Rossella Troia, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, G Fioritoni, MD, Ulf-Henrik Mellqvist, Hans Erik Johnsen, MDDMSc, Sonja Zweegman, MD PhD, Ka Lung Wu, Joana Parreira, MD, Fredrik H. Schjesvold, MD, James D'Rozario, Antonio Palumbo, MD, Michele Cavo
Journal: Blood
Blood (2016) 128 (22): 242.
https://doi.org/10.1182/blood.V128.22.242.242
Published: 2016